LYON, France, March 4, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, announced today that its Focal One platform has been granted Breakthrough Device designation by ...

LYON, France, November 30, 2022-- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic therapeutic ultrasound, today announced that the Company has received approval from French ...

Study confirms feasibility of using Focal One HIFU to treat rectal endometriosis LYON, France,December 19, 2019-- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in therapeutic ...

The relationship between these two endometrial disorders seems to have gone in a full circle; at the beginning of the 20th Century only one pathological definition (adenomyoma) was utilized to ...

Treatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgery “The comparative results from these two cohorts ...

Adenomyosis is a lesser-known but significantly debilitating gynecological disorder that is commonly mistaken for endometriosis. Commonly referred to as the 'evil twin sister' of endometriosis, ...

Adenomyosis is often called the "evil sister" of endometriosis. Adenomyosis is where endometrial tissue grows in the outer muscular walls of the uterus. One-third of people with adenomyosis are ...